Stephen A. Willey is Sr VP & Chief Accting Officer at BioMed Realty Trust Inc (BMR). They have made 5 open-market trades across 1 company since 2012, most recently 2016-01-27.
CIK 0001507554
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BMR | 21,792 | $23K |
Shares reported on the most recent Form 4, priced at the 2016-01-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BMR | SELL | 2015-03-12 | 2015-03-16 | $22.07 | $44K | -6.0% | +0.3% | +0.3% |
| BMR | SELL | 2014-05-12 | 2014-05-13 | $21.00 | $102K | -6.0% | +0.3% | +0.3% |
| BMR | SELL | 2014-03-11 | 2014-03-12 | $20.25 | $161K | -6.0% | +0.3% | +0.3% |
| BMR | SELL | 2012-03-16 | 2012-03-19 | $19.05 | $105K | -6.0% | +0.3% | +0.3% |
| BMR | SELL | 2012-03-13 | 2012-03-15 | $18.60 | $93K | -6.0% | +0.3% | +0.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.